Angioinsight

Minnetonka, MN · Founded 2013 · Privately Held (backing)

Developer of artificial intelligence (AI) diagnostic tools designed to improve the detection and management of cardiovascular disease. Angioinsight is based in Minnetonka, MN and was founded in 2013. It is valued at about $18 million as of Oct 2026, set by institutional fund marks. It has raised $10.5 million.

PMV mark · valuation
$18.0M
Oct 2026
Priced at
—
Total raised
$10.5M
Last round
—
What is Angioinsight worth?
$18.0MPrivateMarketView mark · Oct 2026

Reported valuation; nothing comparable since.

Pro
The prices on Angioinsight
  • ·6 fund marks: filer, period, implied $/share
Pro · $99 a month
List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Angioinsight funding history

No rounds on record

No funding rounds for Angioinsight are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Angioinsight valuation

Angioinsight is valued at approximately $18 million as of Oct 2026. The figure is set by institutional fund marks.

Recent activity

In the last 90 days, Angioinsight's record added 1 institutional fund mark (latest period Jul 2026).

Institutional holders and vehicles

1 SEC-registered fund reported 6 fair-value marks on Angioinsight between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.

How Angioinsight's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Angioinsight, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →

Frequently asked about Angioinsight

What is Angioinsight worth?
Angioinsight is valued at $18.0M as of Oct 2026. Reported valuation; nothing comparable since.
How much has Angioinsight raised?
Angioinsight has raised $10.5M in total funding across its recorded rounds.